Maternal-Fetal Medicine physicians' practice patterns for 22-week delivery management by Edmonds, Brownsyne Tucker et al.
Maternal-Fetal Medicine physicians’ practice patterns for 22-
week delivery management
Brownsyne Tucker Edmonds, MD, MS, MPH1, Fatima McKenzie, MS1, and Barrett K. 
Robinson, MD, MPH2
1Indiana University School of Medicine, Department of Obstetrics and Gynecology, Indianapolis, 
IN
2NorthShore University Health System, University of Chicago, Pritzker School of Medicine, 
Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Evanston, IL
Abstract
Objective—To describe Maternal-Fetal Medicine (MFM) physicians’ practice patterns for 22-
week delivery management.
Mehods—Surveyed 750 randomly-sampled members of the Society of Maternal-Fetal Medicine, 
querying MFMs’ practices and policies guiding 22-week delivery management.
Results—325 (43%) MFMs responded. Nearly all (87%) would offer induction. 28% would 
order steroids, and 12% would perform cesarean for a patient desiring resuscitation. Offering 
induction differed significantly based on the provider’s practice setting, region, religious service 
attendance, and political affiliation. In multivariable analyses, political affiliation remained a 
significant predictor of offering induction (p=.03).
Conclusions—Most MFMs offer induction for PPROM at 22 weeks. A noteworthy proportion is 
willing to order steroids and perform cesarean. Personal beliefs and practice characteristics may 
contribute to these decisions. While little is known about the efficacy of these interventions at 22 
weeks, some MFMs will offer obstetrical intervention if resuscitation is intended.
Keywords
periviability; extreme prematurity; physician’s practice patterns; obstetric delivery; premature 
obstetric labor
Introduction
Recent decades have seen substantial advancements in neonatal intensive care and marked 
improvements in neonatal survival. With these advancements, the threshold for obstetricians 
to provide antenatal interventions to optimize neonatal outcomes has decreased to earlier and 
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earlier gestational ages.[1–5] In fact, in the recent executive summary reporting the findings 
of a joint workshop on periviable birth, the definition of ‘periviable’ was broadened to 
encompass the window from 20 to 25 6/7 weeks gestation age.[6] Though relatively little 
data are available to inform obstetrical decision-making at the lower limits of viability, 
increasingly, reports of survival at 22 weeks,[7–9] have led providers in some institutions to 
consider offering resuscitation and attendant antenatal interventions (e.g. steroid 
administration) as early as 22 weeks gestation. Such interventions are not without 
controversy, as many would argue that the chances of survival are too low—and the 
healthcare costs and pain and suffering of the neonate, too great—to justify the practice, 
while others might argue that that risk-benefit assessment should be left to individual 
families to negotiate.
It is unclear how widespread these practices are. Moreover, little is known about the 
institutional and/or provider characteristics associated with offering these earlier 
interventions. In an initial effort to fill this gap in our current understanding of periviable 
practice, we conducted a survey to characterize Maternal-Fetal Medicine (MFM) physicians’ 
practice patterns for 22 week delivery management.
Methods
With approval from Indiana University’s Institutional Review Board, we mailed surveys to 
750 randomly sampled members of the Society of Maternal-Fetal Medicine. We included 
physicians identified through the Society of Maternal-Fetal Medicine’s membership mailing 
list who designated their area of primary specialization as Maternal-Fetal Medicine. 
Members were excluded from the study population if they indicated that they worked in 
General Obstetrics and Gynecology, ‘Gyn-only’ practice settings, or Gyn subspecialties 
(REI, Uro-gynecology, or Gyn-Oncology). Three mailings were administered, after which, 
members were considered nonresponders if they had not returned the survey.
Study participants received a self-administered survey instrument comprised of clinical case 
vignettes and a 3-page physician questionnaire, which covered a range of topics including: 
physician’s knowledge of periviable survival rates; their institutional, professional and 
personal thresholds for resuscitation and cesarean delivery; and a number of 
sociodemographic and practice characteristics. Items pertaining to imminent or inevitable 
22-week delivery management were specifically developed to determine the physicians’ 
practice patterns with regards to 1) labor induction 2) steroid administration and 3) cesarean 
delivery for breech presentation (Supplemental Digital Content S1). These three 
dichotomous response (yes/no) items served as our outcome measures. The questionnaire 
also included items that queried a number of sociodemographic and practice setting 
characteristics, including: age, number of years out of residency, practice state, practice 
setting, race, sex, marital and parenting status, political views, religion, religiosity, 
malpractice experience, resident supervision, and consultation practices.
We conducted all analyses with SPSS v. 22 (IBM SPSS Statistics® 2222.0, IBM Corp©, 
Armonk, NY). We computed descriptive statistics with univariate analyses. Bivariate 
analysis, including Student’s t test, Chi2 analyses, and Fisher’s exact test, were utilized to 
Tucker Edmonds et al. Page 2
J Matern Fetal Neonatal Med. Author manuscript; available in PMC 2017 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
test the association between physician characteristics and practice settings with steroid, 
cesarean, and induction practice patterns. Statistical significance was defined at alpha 
<=0.05. Logistic regression was used for multivariable analyses. We utilized a threshold of 
p<=0.10 in the bivariate comparisons to determine which physician and/or practice-setting 
characteristics were included in each outcome model. Then, for each outcome, we 
constructed a logistic regression model to determine predictors of physician intervention.
Results
325 (43%) MFMs returned surveys. Table 1 describes practice-setting and personal 
characteristics of the respondents. On average, respondents had been in practice for 22 years. 
Though a slight majority of respondents lived in the Northeast and South (54%), all regions 
were roughly evenly represented (21–28%). Furthermore, university-based (43%), hospital-
based (25%) and private practice (23%) settings were well represented. Respondents were 
predominantly white (74%); male (59%); married (83%) and parenting (87%). A noteworthy 
proportion (10%) of respondents were parents of children with special needs. Half of the 
respondents identified as Protestant or Catholic, but the majority reported low attendance at 
religious services (59%) and placed low importance on religion in their lives (55%). Political 
views were varied, with the majority identifying as liberal (38%) or moderate (34%).
Table 2 describes institutional policies and personal practices, as reported by the physicians. 
On average, the MFMs reported that they had managed 13 periviable deliveries in the last 6 
months. Most reported that their states and hospitals allowed labor induction at 22 weeks 
(85% and 75%, respectively). If allowed, nearly all (87%) would offer induction to 22-week 
patients. Conversely, roughly a quarter (28%) of MFMs would order steroids at 22 weeks, 
and 12% would perform cesarean at 22 weeks if a patient desired resuscitation.
Table 3 describes bivariate associations between provider characteristics and practice 
patterns for induction, steroids, and cesarean for 22 week delivery management. Offering 
induction differed significantly based on the providers’ region (p=.007), practice setting (p=.
001), political views (p=.004), and religious service attendance (p=.012). In particular, those 
practicing in the northeastern and southern U.S.; those in university-based practice; those 
with liberal political views; and those with low religious service attendance were the most 
likely to offer induction. For steroid administration, only religion (p=.037) was associated 
with practice patterns. Specifically, providers identifying as Protestant or Catholic were 
more likely to order steroids. No significant associations were identified between provider 
characteristics and willingness to perform cesarean.
After adjusting for covariates, political affiliation remained a statistically significant 
predictor of offering induction (p=.029). Physicians with conservative political views were 
less likely to offer induction compared to those with liberal views (AOR=.32, 95% CI 0.12, 
0.89).
Discussion
We set out to characterize Maternal-Fetal Medicine (MFM) physicians’ practice patterns for 
22 week delivery management and found that 87% of MFM’s would offer induction to 22-
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week patients; while 27% would order steroids and 12% would perform cesarean at 22 
weeks if a patient desired resuscitation. We found that these practice patterns were 
associated with provider and practice setting characteristics such as religious service 
attendance and region of practice. In multivariable analyses, only political affiliation 
maintained a statistically significant association with induction practice patterns.
Relatively little research, to-date, has explored obstetrical practices at 22 weeks. A previous 
study of SMFM members revealed that 65% of MFMs would offer cesarean at 23 weeks, 
despite reporting that they did not believe that there was an evidence base to support this 
management strategy.[10] It is unclear what accounts for this disconnect between evidenced-
based practice and clinical decision-making. Litigation concerns could be argued, though, in 
our study, we found no association between prior malpractice history and 22 week 
intervention. Alternatively, previous qualitative work on obstetrical decision-making for 
periviable delivery management suggests that patient preferences may be prioritized in the 
setting of insufficient or inconclusive data, particularly in the 23 week window.[11] 
However, in the 22 week window, national statistics for survival and survival without 
impairment remain poor, with the most optimistic estimates of 9% and 5%, respectively.[12] 
In this setting, it may be more difficult to justify the deferral to patient preference.
With regards to induction, we found that the vast majority (87%) of MFMs were willing to 
offer induction to patients presenting with PPROM at 22 weeks. This stands in stark contrast 
to the results of a previous study of generalists, which found that generalists were unlikely to 
offer induction when presented with a vignette describing PPROM at 22 weeks, even when 
the patient in the vignette planned to pursue palliation.[13] Furthermore, generalists were 
unlikely to offer steroids or perform cesarean delivery, even among patients planning to 
attempt resuscitation.[13] That study found that generalists’ management decisions were 
primarily driven by gestational age. MFMs may be more attentive to maternal infectious 
risks, which could explain the difference in induction offerings.
A number of limitations must be considered in interpreting the findings of our study. Though 
we aimed to survey a nationally-representative sample of MFMs, we realize that a sample 
obtained through the Society of Maternal-Fetal Medicine may not be generalizable to all 
MFMs. Moreover, those willing to respond to the survey may be more interested in research 
and evidence-based guidelines for care, potentially underestimating the degree of practice 
variation and early intervention. Furthermore, our methodology was limited to self-report. 
We cannot know if physician responses accurately reflect their behavior or their institution’s 
policies. Because this was the first time that many of these associations had been explored, 
we chose not to adjust for multiple comparisons, since this procedure can obscure potential 
findings in exploratory contexts.[14] However, we do note that failing to control for multiple 
comparisons increases our likelihood of type 1 error.
Despite these limitations, our study addresses a novel and clinically important question. 
With regards to periviable intervention, “Is 22 the new 23?” While the large majority of 
physicians would not perform cesarean for these patients, more than a few would do so upon 
patient request. Given the poor neonatal survival, long-term maternal morbidity, and 
implications for future pregnancies, these trends toward earlier obstetrical interventions 
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merit further attention, particularly in light of the lack of data to suggest that cesarean 
confers a survival advantage at such an early gestation. These data highlight competing 
ethical and professional duties with regards to patient autonomy and non-maleficence.[15] In 
general, physicians want patients to be able to receive appropriate interventions upon request 
if properly counselled. However, it is not clear that obstetricians should offer interventions 
that increase maternal morbidity with no proven benefit for the neonate, nor that physicians 
are obligated to accommodate patient requests for such interventions. These issues, along 
with practical considerations about cost, resource utilization, and patient-oriented outcomes 
will warrant further study as the field continues to extend the limits of viability to earlier 
gestations.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 1
Study Population (N=325)
N (%)
Age
30–39 19 (6)
40–49 87 (27)
50–59 133 (41)
60–69 72 (22)
70 or over 14 (4)
No. of years post-residency 22 (mean); 2–49 (range)
No. of periviable deliveries (last 6
months)
13 (mean); 2–49 (range)
Region
Northeast 83 (26)
South 92 (28)
Midwest 69 (21)
West 76 (23)
Missing 5 (2)
Practice Setting
Private Practice 82 (25)
HMO 6 (2)
Hospital-owned 74 (23)
University-based 141 (43)
Other 21 (7)
Missing 1 (0)
Race/Ethnicity
White 241 (74)
Black 19 (6)
Hispanic 10 (3)
Asian 41 (13)
Other 4 (1)
Missing 10 (3)
Sex
Male 191 (59)
Female 134 (41)
Marital Status
Single 19 (6)
Married or partnered 270 (83)
Divorced or separated 28 (9)
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N (%)
Other 4 (1)
Missing 4 (1)
Parent
Yes 284 (87)
No 39 (12)
Missing 2 (1)
Parent of Child with Special Needs
Yes 32 (10)
No 291 (90)
Missing 2 (1)
Political Views
Liberal 124 (38)
Moderate 109 (34)
Conservative 74 (23)
Other 13 (4)
Missing 5 (2)
Religion
Protestant or Catholic 162 (50)
Jewish 46 (14)
Muslim, Buddhist, Hindu 20 (6)
Other 30 (9)
None 64 (20)
Missing 3 (1)
Attendance at Religious Services
High Attenders 128 (39)
Low Attenders 193 (59)
Missing 4 (1)
Importance of Religion
High Importance 102 (31)
Low Importance 177 (55)
N/A. No religion. 402 (12)
Missing 6 (2)
Malpractice Lawsuit
Yes 129 (40)
No 193 (59)
Missing 3 (1)
Supervise Residents
Yes 240 (74)
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N (%)
No 80 (24)
Missing 5 (2)
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Table 2
22 Week Policies and Practices (N=325)
N %
Induction Allowed at Hospital
Yes 244 75.1
No 76 23.4
Missing 5 1.5
Induction Allowed in State
Yes 276 84.9
No 33 10.2
Missing 16 4.9
Offer Induction
Yes 284 87.4
No 37 11.4
Missing 4 1.2
Offer Steroids
Yes 92 28.3
No 228 70.2
Missing 5 1.5
Offer Cesarean
Yes 39 12.0
No 281 86.5
Missing 5 1.5
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